Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 22 records, 3 pages
Search For: Antisense Oligonucleotides
Global Antisense Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Medical Care
According to our (Global Info Research) latest study, the global Antisense Oligonucleotides market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Antisense Oligonucleotides (ASO) Drug Supply, Demand and Key Producers, 2024-2030
10 Feb 2024
Pharma & Healthcare
Antisense Oligonucleotides (ASO) Drug
The global Antisense Oligonucleotides (ASO) Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Antisense Oligonucleotides (ASO) Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
03 Jan 2024
Pharma & Healthcare
Antisense Oligonucleotides (ASO) Drug
According to our (Global Info Research) latest study, the global Antisense Oligonucleotides (ASO) Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Antisense Oligonucleotides (ASOs) Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
21 May 2024
Pharma & Healthcare
Antisense Oligonucleotides (ASOs) Drugs
Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).
USD3480.00
Add To Cart
Global Antisense Oligonucleotides (ASOs) Drugs Supply, Demand and Key Producers, 2024-2030
21 May 2024
Pharma & Healthcare
Antisense Oligonucleotides (ASOs) Drugs
Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).
USD4480.00
Add To Cart
Global CNS Specific Antisense Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Service & Software
CNS Specific Antisense Oligonucleotides
According to our (Global Info Research) latest study, the global CNS Specific Antisense Oligonucleotides market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Antisense Oligonucleotides (ASO) Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
14 May 2024
Pharma & Healthcare
Antisense Oligonucleotides (ASO) Therapy
Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases
USD3480.00
Add To Cart
Global Antisense Oligonucleotides (ASO) Therapy Supply, Demand and Key Producers, 2024-2030
14 May 2024
Pharma & Healthcare
Antisense Oligonucleotides (ASO) Therapy
Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases
USD4480.00
Add To Cart
Global Antisense Oligonucleotides Drugs for ATTR Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
13 Aug 2024
Pharma & Healthcare
Antisense Oligonucleotides Drugs for ATTR
Antisense oligonucleotide(ASO)drugs represent a groundbreaking approach for treating transthyretin amyloidosis(ATTR),a condition characterized by the accumulation of misfolded transthyretin proteins that lead to organ damage.These ASO drugs work by targeting and degrading the mRNA that encodes for transthyretin,thus reducing its production at the source.
USD3480.00
Add To Cart
Global Antisense Oligonucleotides Drugs for ATTR Supply, Demand and Key Producers, 2024-2030
13 Aug 2024
Pharma & Healthcare
Antisense Oligonucleotides Drugs for ATTR
Antisense oligonucleotide(ASO)drugs represent a groundbreaking approach for treating transthyretin amyloidosis(ATTR),a condition characterized by the accumulation of misfolded transthyretin proteins that lead to organ damage.These ASO drugs work by targeting and degrading the mRNA that encodes for transthyretin,thus reducing its production at the source.
USD4480.00
Add To Cart
- 1
- 2
- 3
Go To Page
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Antisense Oligonucleotides
Total: 22 records, 3 pages
According to our (Global Info Research) latest study, the global Antisense Oligonucleotides market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
The global Antisense Oligonucleotides (ASO) Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Antisense Oligonucleotides (ASO) Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).
USD3480.00
Add To Cart
Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global CNS Specific Antisense Oligonucleotides market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases
USD3480.00
Add To Cart
Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases
USD4480.00
Add To Cart
Antisense oligonucleotide(ASO)drugs represent a groundbreaking approach for treating transthyretin amyloidosis(ATTR),a condition characterized by the accumulation of misfolded transthyretin proteins that lead to organ damage.These ASO drugs work by targeting and degrading the mRNA that encodes for transthyretin,thus reducing its production at the source.
USD3480.00
Add To Cart
Antisense oligonucleotide(ASO)drugs represent a groundbreaking approach for treating transthyretin amyloidosis(ATTR),a condition characterized by the accumulation of misfolded transthyretin proteins that lead to organ damage.These ASO drugs work by targeting and degrading the mRNA that encodes for transthyretin,thus reducing its production at the source.
USD4480.00
Add To Cart
- 1
- 2
- 3
Go To Page
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>